Clinical trials provide pivotal evidence on drug efficacy and safety. The evidence, information from clinical trials, is currently used by regulatory decision makers in marketing authorization decisions, but only in an implicit manner. For clinical trials information to be used in a transparent...

In evidence-based medicine, meta-analysis is an important statistical technique for combining the findings from independent clinical trials which have attempted to answer similar questions about treatment's clinical eectiveness [1]. Normally, such meta-analyses are pair-wise treatment...

In evidence-based medicine, meta-analysis is an important statistical technique for combining the findings from independent clinical trials which have attempted to answer similar questions about treatment's clinical eectiveness [1]. Normally, such meta-analyses are pair-wise treatment...

A standard practice in health economic evaluation is to monetize health effects by assuming a certain societal willingness-to-pay per unit of health gain. Although the resulting net monetary benefit (NMB) is easy to compute, the use of a single willingness-to-pay threshold assumes expressibility...

In our previous work published in this journal, we showed how the Hit-And-Run (HAR) procedure enables efficient sampling of criteria weights from a space formed by restricting a simplex with arbitrary linear inequality constraints. In this short communication, we note that the method for...

Models for Multiple Criteria Decision Analysis (MCDA) often separate per-criterion attractiveness evaluation from weighted aggregation of these evaluations across the different criteria. In simulation-based MCDA methods, such as Stochastic Multicriteria Acceptability Analysis, uncertainty in the...